An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance.

MLA

Raykar, Neha, et al. “An Extended Cost-Effectiveness Analysis of Schizophrenia Treatment in India under Universal Public Finance.” Cost Effectiveness and Resource Allocation : C/E, vol. 14, July 2016, p. 9. EBSCOhost, https://doi.org/10.1186/s12962-016-0058-z.

APA

Raykar, N., Nigam, A., & Chisholm, D. (2016). An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance. Cost Effectiveness and Resource Allocation : C/E, 14, 9. https://doi.org/10.1186/s12962-016-0058-z

Chicago

Raykar, Neha, Aditi Nigam, and Dan Chisholm. 2016. “An Extended Cost-Effectiveness Analysis of Schizophrenia Treatment in India under Universal Public Finance.” Cost Effectiveness and Resource Allocation : C/E 14 (July): 9. doi:10.1186/s12962-016-0058-z.